Patient dosimetry during coronary interventions: a comprehensive analysis - 26/08/11
Abstract |
Background |
We performed a detailed analysis of patient radiation during coronary interventions, comparing dose measurements to established dose reference levels, assessing coronary artery doses, and estimating total radiation risk of fatal cancer.
Methods |
We prospectively examined 281 patients who were subjected to 307 percutaneous coronary interventions.
Results |
The mean kerma area product (KAP) per procedure was 82.1 ± 47.9 Gy.cm2. Corresponding values for fluoroscopy and digital cineangiography were 28.3 ± 25.5 Gy.cm2 and 53.8 ± 35.5 Gy.cm2, respectively, and exposure times were 13.1 ± 6.8 minutes (87%) and 2.0 ± 1.5 minutes (13%), respectively. The right anterior oblique caudal and left anterior oblique cranial projections accounted for the highest amount of KAP (24.0% and 23.1%, respectively) compared with other projections. The maximum recorded skin-dose was 182 mGy. Performing a representative procedure on a phantom, the effective dose was 14.9 mSv. The mean coronary dose was 61.7 ± 38.2 mGy, with a highest calculated dose of 220.1 mGy. The third quartile of KAP measurements was 105 Gy.cm2, the 95th percentile was 175 Gy.cm2, and the mean value of KAP measurements was 82 Gy.cm2. The total risk for the development of fatal cancer was calculated as 83 cases for every 100,000 patients subjected to coronary intervention.
Conclusions |
A detailed analysis of patient radiation during coronary interventions is presented. Coronary doses and total radiation risk of fatal cancer are also calculated, and a method for establishing dose reference level values is proposed.
Le texte complet de cet article est disponible en PDF.Plan
 | Supported in part by the European Commission's Radiation Protection Research Program DIMOND III (Measures for Optimising Radiological Information and Dose in Digital Imaging and Interventional Radiology; contract number: FIGM CT2000-00061). |
Vol 147 - N° 3
P. 468-475 - mars 2004 Retour au numéro
Article précédent
- Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation
- James L Orford, Panayotis Fasseas, Steven Melby, Kelli Burger, Steven R Steinhubl, David R Holmes, Peter B Berger
- Frequency and time course of reocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus wiktor stent implantation: results from the Mayo-Japan Investigation for Chronic Total Occlusion (MAJIC) Trial
- Hideo Tamai, Peter B Berger, Etsuo Tsuchikane, Takahiko Suzuki, Hideo Nishikawa, Tadanori Aizawa, Kenshi Fujii, Youichi Nozaki, Eisho Kyo, Toru Kobayashi, Johan Reiber, Anton W.M Van Weert, MAJIC Investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?